BiOrion Technologies BV - Company Review
BiOrion Technologies BV - Company ReviewSummary
BiOrion Technologies BV (BiOrion) is a clinical stage biopharmaceutical drug discovery company that develops therapeutic drugs for the treatment of fibrosis and fibroblast-associated cancers. The company offers drug development programs, which are designed at therapies and diagnostics. Its technology is used to deliver therapeutic agents to fibrotic tissues and cancer such as peptides, large proteins, liposomes, cytokines, prostaglandins, and cytostatics, among others. BiOrion’s products are used for the treatment of idiopathic pulmonary fibrosis (IPF), nonalcoholic steatohepatitis, lung and liver fibrosis, hepatic fibrosis, renal fibrosis, systemic sclerosis, pancreatic cancer and diabetic nephropathy. The company serves healthcare and pharmaceutical industries. BiOrion is headquartered in Groningen, the Netherlands.
This comprehensive company report of BiOrion Technologies BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.